• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制剂FTY720可下调1-磷酸鞘氨醇G蛋白偶联受体。

The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.

作者信息

Gräler Markus H, Goetzl Edward J

机构信息

University of California, Room UB-8B, UC Box 0711, 533 Parnassus Ave., San Francisco, CA 94143-0711, USA.

出版信息

FASEB J. 2004 Mar;18(3):551-3. doi: 10.1096/fj.03-0910fje. Epub 2004 Jan 8.

DOI:10.1096/fj.03-0910fje
PMID:14715694
Abstract

FTY720 is an immunosuppressant that reduces circulating levels of naïve lymphocytes by increasing their localization and sequestration in secondary lymphoid organs. It is considered to be an agonist for sphingosine 1-phosphate (S1P) G protein-coupled receptors (GPCRs) after phosphorylation at micromolar concentrations. We now describe its nonagonist and noncompetitive inhibitory activity at low nanomolar concentrations for types 1 and 5 S1P-GPCRs and of moderate potency for type 2 S1P-GPCRs. FTY720 blocks S1P signaling through S1P1,2,5 by inducing their internalization and intracellular partial degradation without affecting S1P3 or S1P4. S1P-R internalization is maximal several hours after only seconds of incubation with FTY720 at 37 degrees C and washing, and continues for days before recovery of surface expression and functions. The timing and extent of S1P-R internalization are highly dependent on FTY720 concentration. FTY720 is therefore an S1P-GPCR-selective and noncompetitive inhibitor with a unique mechanism of action.

摘要

FTY720是一种免疫抑制剂,它通过增加初始淋巴细胞在次级淋巴器官中的定位和滞留来降低其循环水平。在微摩尔浓度下磷酸化后,它被认为是1-磷酸鞘氨醇(S1P)G蛋白偶联受体(GPCR)的激动剂。我们现在描述了它在低纳摩尔浓度下对1型和5型S1P-GPCR具有非激动剂和非竞争性抑制活性,对2型S1P-GPCR具有中等效力。FTY720通过诱导1型、2型和5型S1P-GPCR内化和细胞内部分降解来阻断S1P信号传导,而不影响S1P3或S1P4。在37℃下与FTY720孵育仅数秒并洗涤后,S1P受体内化在数小时后达到最大值,并在表面表达和功能恢复之前持续数天。S1P受体内化的时间和程度高度依赖于FTY720浓度。因此,FTY720是一种具有独特作用机制的S1P-GPCR选择性非竞争性抑制剂。

相似文献

1
The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.免疫抑制剂FTY720可下调1-磷酸鞘氨醇G蛋白偶联受体。
FASEB J. 2004 Mar;18(3):551-3. doi: 10.1096/fj.03-0910fje. Epub 2004 Jan 8.
2
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.淋巴细胞从胸腺和外周淋巴器官的输出依赖于S1P受体1。
Nature. 2004 Jan 22;427(6972):355-60. doi: 10.1038/nature02284.
3
FTY720 modulates human oligodendrocyte progenitor process extension and survival.FTY720调节人少突胶质前体细胞的突起延伸和存活。
Ann Neurol. 2008 Jan;63(1):61-71. doi: 10.1002/ana.21227.
4
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.鞘氨醇-1-磷酸受体激动剂在啮齿动物中的免疫细胞调节及心血管效应是通过不同的受体亚型介导的。
J Pharmacol Exp Ther. 2004 May;309(2):758-68. doi: 10.1124/jpet.103.062828. Epub 2004 Jan 27.
5
Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.基于4(5)-苯基咪唑的鞘氨醇-1-磷酸酯类似物和FTY720的合成:强效S1P1受体激动剂的发现
Bioorg Med Chem Lett. 2005 Aug 1;15(15):3568-72. doi: 10.1016/j.bmcl.2005.05.097.
6
Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.1-磷酸鞘氨醇受体1在淋巴细胞从次级淋巴组织和胸腺中逸出过程中的作用。
Cell Mol Immunol. 2006 Feb;3(1):11-9.
7
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.1-磷酸鞘氨醇受体激动剂对淋巴细胞运输的改变
Science. 2002 Apr 12;296(5566):346-9. doi: 10.1126/science.1070238. Epub 2002 Mar 28.
8
FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.FTY720抑制鞘氨醇-1-磷酸(S1P)介导的内皮修复:与S1P1受体表面表达的关系。
Biochem Biophys Res Commun. 2008 Jun 13;370(4):603-8. doi: 10.1016/j.bbrc.2008.03.144. Epub 2008 Apr 8.
9
Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.顺-4-甲基鞘氨醇是一种鞘氨醇-1-磷酸受体调节剂。
Biochem Pharmacol. 2011 Mar 1;81(5):617-25. doi: 10.1016/j.bcp.2010.12.002. Epub 2010 Dec 14.
10
Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.神经 S1P 信号作为口服 FTY720(芬戈莫德)在多发性硬化症中作用机制的新发现。
Arch Pharm Res. 2010 Oct;33(10):1567-74. doi: 10.1007/s12272-010-1008-5. Epub 2010 Oct 30.

引用本文的文献

1
Regulatory T cell and endothelial cell crosstalk.调节性T细胞与内皮细胞的相互作用。
Nat Rev Immunol. 2025 Apr 1. doi: 10.1038/s41577-025-01149-2.
2
Siponimod supports remyelination in the non-supportive environment.西普尼莫德在非支持性环境中支持髓鞘再生。
Sci Rep. 2025 Feb 4;15(1):4216. doi: 10.1038/s41598-025-87825-8.
3
Effect of Different Treatments on Retinal Thickness Changes in Patients With Multiple Sclerosis: A Review.不同治疗方法对多发性硬化症患者视网膜厚度变化的影响:一项综述
CNS Neurosci Ther. 2025 Jan;31(1):e70225. doi: 10.1111/cns.70225.
4
The sphingosine-1-phosphate signaling pathway (sphingosine-1-phosphate and its receptor, sphingosine kinase) and epilepsy.鞘氨醇-1-磷酸信号通路(鞘氨醇-1-磷酸及其受体、鞘氨醇激酶)与癫痫
Epilepsia Open. 2025 Feb;10(1):55-73. doi: 10.1002/epi4.13112. Epub 2024 Dec 27.
5
Unique pharmacological properties of etrasimod among S1P receptor modulators.依曲莫德在S1P受体调节剂中具有独特的药理学特性。
FEBS Open Bio. 2025 Jan;15(1):108-121. doi: 10.1002/2211-5463.13907. Epub 2024 Nov 20.
6
Endosomal fusion of pH-dependent enveloped viruses requires ion channel TRPM7.pH 依赖性包膜病毒的内体融合需要离子通道 TRPM7。
Nat Commun. 2024 Oct 1;15(1):8479. doi: 10.1038/s41467-024-52773-w.
7
A Limited Number of Amino Acid Permeases Are Crucial for Survival and Virulence.有限数量的氨基酸通透酶对生存和毒力至关重要。
Int J Microbiol. 2024 Aug 8;2024:5566438. doi: 10.1155/2024/5566438. eCollection 2024.
8
Cystathionine γ-lyase-derived HS negatively regulates thymic egress via allosteric inhibition of sphingosine-1-phosphate lyase.胱硫醚γ-裂解酶衍生的 HS 通过别构抑制鞘氨醇 1-磷酸酶负调节胸腺迁出。
Acta Pharmacol Sin. 2024 Nov;45(11):2366-2379. doi: 10.1038/s41401-024-01322-8. Epub 2024 Jun 24.
9
Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.外周血 CD8+T 细胞转录组的途径分析显示多发性硬化症和胶质母细胞瘤中鞘脂信号的差异调节。
PLoS One. 2024 Jun 11;19(6):e0305042. doi: 10.1371/journal.pone.0305042. eCollection 2024.
10
Small-molecule agents for cancer immunotherapy.用于癌症免疫治疗的小分子药物。
Acta Pharm Sin B. 2024 Mar;14(3):905-952. doi: 10.1016/j.apsb.2023.12.010. Epub 2023 Dec 16.